Title: Technological Advancements to Boost Respiratory Disease Testing Market by 2024
1Cancer Profiling Market size is projected to
experience significant growth from 2017 to 2024.
Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
2Regional Analysis of Cancer Profiling Market
- Rising prevalence of cancer worldwide and huge
funding available for oncology research are the
major factors driving global cancer profiling
market growth. In addition, the increase in the
utility of biomarkers and high demand for the
point-of-care diagnostic testing will fuel the
demand for the oncology profiling over the coming
years. - The obtainability of custom-made medical
treatment that will suit specific physiognomies,
preferences, and requirements of patients coupled
with intensifying compliance for the tumor
profiling in developing economies should propel
the industry. - According to the International Agency for
Research on Cancer (IARC), the global burden for
cancer by 2030, is projected to reach 21.7
million new cases. As per American Cancer
Society, by end of 2017 there will be 1,688,780
new cases of cancer identified in the U.S. High
capital investment and rising demand for the
personalized medicine are other major factors
boosting the industry size. - The forthcoming disease burden will possibly
remain higher since adoption of western
lifestyle, including inactiveness, poor diet,
smoking, etc. High associated cost with profiling
and dearth of trained specialists can limit the
business growth during the forecast years. -
3- Personalized medicine reduces possibility of
adverse side effects and additional healthcare
expenses. Moreover, capability to take health
decisions regarding disease prediction and
prevention as well as prior disease intervention
is being possible because of personalized
medicines. - Genomics will witness lucrative growth due to its
wide-ranging clinical, diagnostics and research
applications. - Increasing government funding and grants along
with investments are the determinants to fuel the
cancer profiling market growth during the
forecast timeframe. Moreover, the increased
adoption of the genomics in RD and research
studies offers immense growth opportunities. - Next-generation sequencing (NGS) accounted for
largest share in cancer profiling technology in
2016. Associated advantages include recognition
of transmutation, advanced genome with reduction
in cost, high speed and sensitivity. -
4Competitive Market Share of Cancer Profiling
Market
- Several initiatives undertaken to prevent the
breast and colorectal cancers should fuel U.S.
cancer profiling market growth. For instance, the
Molecular Profiling Breast Cancer (MPBC) is
altering medical training and improving
management of breast oncology in the U.S.
Moreover, the colorectal cancer is the second
major cause of death in U.S. and there is
necessity to profile and detect tumors at initial
stages in order to provide appropriate treatment. - China will foresee lucrative growth over the
coming years due to rising demand for the better
healthcare service coupled with increasing
occurrence of tumor. Furthermore, growing number
of the contract research organizations (CROs) and
major international players focusing on
developing economies to expand their business
will drive regional share.
5 Browse Full Market Research Report On Cancer
Profiling Market _at_ http//bit.ly/2uuKfIR
Request for an in-depth table of contents for
this report _at_ http//bit.ly/2tPdW4E
6Stay In Touch Website www.gminsights.com Soci
al Media